Overview

  • Product name
    Anti-C1orf167 antibody
  • Description
    Rabbit polyclonal to C1orf167
  • Tested applications
    Suitable for: ICC/IF, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    antigen sequence, corresponding to amino acids 1031-1101 (WCEVVRDTGV LRAQHQAFQD GLRRRALGAV FATWREAQEV AAGAQEQRVA QASLARWRSC GQQGQEDGQQ K) of Human C1orf167.

  • Positive control
    • Human kidney tissue.

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage buffer
    pH: 7.20
    Preservative: 0.02% Sodium azide
    Constituents: 59% PBS, 40% Glycerol
  • Concentration information loading...
  • Purity
    Immunogen affinity purified
  • Clonality
    Polyclonal
  • Isotype
    IgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab122536 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF Use a concentration of 1 - 4 µg/ml.

Recommend PFA Fixation and Triton X-100 treatment

IHC-P 1/200 - 1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Target

Anti-C1orf167 antibody images

  • Immunofluorescent staining of Human cell line U-2 OS shows positivity in plasma membrane. Recommended concentration of ab122536 1-4 µg/ml. Cells treated with PFA/Triton X-100.
  • ab122536, at 1/400 dilution, staining C1orf167 in paraffin-embedded Human kidney tissue by Immunohistochemistry.

References for Anti-C1orf167 antibody (ab122536)

ab122536 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab122536.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up